Skip to main content

Advertisement

Fig. 1 | BMC Cancer

Fig. 1

From: Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC

Fig. 1

Overview of patient recruitment and conduct of molecular assays in Trans-NCC0901. Of the 172 patients in the initial NCC0901 randomised controlled phase II/III cohort, 85 patients were recruited from 142 survivors to the exploratory biomarker study. γH2AX and FLICA assays were performed in ex vivo irradiated G0 lymphocytes of patients and the intra- and inter-patient heterogeneity in response determined

Back to article page